As of 2025-10-31, the Relative Valuation of Aker Biomarine AS (AKBM.OL) is 407.40 NOK. This relative valuation is based on P/E multiples. With the latest stock price at 88.90 NOK, the upside of Aker Biomarine AS based on Relative Valuation is 358.3%.
The range of the Relative Valuation is 329.12 - 498.66 NOK.
| Range | Selected | |
| Trailing P/E multiples | 21.4x - 25.0x | 22.0x |
| Forward P/E multiples | 16.5x - 19.3x | 18.8x |
| Fair Price | 329.12 - 498.66 | 407.40 |
| Upside | 270.2% - 460.9% | 358.3% |
| Date | P/E |
| 2025-10-30 | 4.46 |
| 2025-10-29 | 4.49 |
| 2025-10-28 | 4.45 |
| 2025-10-27 | 4.36 |
| 2025-10-24 | 4.41 |
| 2025-10-23 | 4.32 |
| 2025-10-22 | 4.34 |
| 2025-10-21 | 4.35 |
| 2025-10-20 | 4.27 |
| 2025-10-17 | 4.29 |
| 2025-10-16 | 4.35 |
| 2025-10-15 | 4.33 |
| 2025-10-14 | 4.27 |
| 2025-10-13 | 4.30 |
| 2025-10-10 | 4.38 |
| 2025-10-09 | 4.51 |
| 2025-10-08 | 4.55 |
| 2025-10-07 | 4.54 |
| 2025-10-06 | 4.58 |
| 2025-10-03 | 4.61 |
| 2025-10-02 | 4.61 |
| 2025-10-01 | 4.70 |
| 2025-09-30 | 4.65 |
| 2025-09-29 | 4.45 |
| 2025-09-26 | 4.23 |
| 2025-09-25 | 4.23 |
| 2025-09-24 | 4.36 |
| 2025-09-23 | 4.47 |
| 2025-09-22 | 4.51 |
| 2025-09-19 | 4.61 |
| 2025-09-18 | 4.62 |
| 2025-09-17 | 4.43 |
| 2025-09-16 | 4.39 |
| 2025-09-15 | 4.45 |
| 2025-09-12 | 4.49 |
| 2025-09-11 | 4.51 |
| 2025-09-10 | 4.55 |
| 2025-09-09 | 4.57 |
| 2025-09-08 | 4.55 |
| 2025-09-05 | 4.51 |
| 2025-09-04 | 4.41 |
| 2025-09-03 | 4.37 |
| 2025-09-02 | 4.46 |
| 2025-09-01 | 4.51 |
| 2025-08-29 | 4.26 |
| 2025-08-28 | 4.21 |
| 2025-08-27 | 4.21 |
| 2025-08-26 | 4.14 |
| 2025-08-25 | 4.10 |
| 2025-08-22 | 4.13 |